Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

ED50 of Intrathecal Hyperbaric 2% Prilocaine in Transperineal Magnetic Resonance Imaging-Transrectal Ultrasound Fusion Guided Biopsy

NCT05649020 is registered in ClinicalTrials.gov with Hospital General Universitario Gregorio Marañon as lead sponsor.

NCT NCT05649020
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05649020 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
ED50 of Intrathecal Hyperbaric 2% Prilocaine in Transperineal Magnetic Resonance Imaging-Transrectal Ultrasound Fusion Guided Biopsy
Lead sponsor
Hospital General Universitario Gregorio Marañon
Phase
Phase 4
Overall status
Unknown status
Start date
November 24, 2022
Completion date
March 31, 2024
Enrollment
90 (estimated)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

evaluate requirements of 2% prilocaine in mr-uf prostate biopsy